Dave Bassett:
CLASS OF 1971
Reading Memorial High SchoolClass of 1971
Reading, MA
Harvard Extension SchoolClass of 1998
Cambridge, MA
Northeastern Universty - Graduate SchoolClass of 1984
Boston, MA
University of MaineClass of 1975
Orono, ME
Dave's Story
News from work: Amgen announced that the U.S. Food and Drug Administration (FDA) has approved Prolia for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factor...Expand for more
s for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.
Register for Free to view all details!
Yearbooks
Reunions
